Should insurance be responsible for the cost of care while a patient is enrolled in a clinical trial?

被引:0
|
作者
Weiss, Patricia A. [1 ]
机构
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
关键词
D O I
10.1188/08.CJON.153-154
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:153 / 154
页数:2
相关论文
共 50 条
  • [41] Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care
    Sidana, Surbhi
    Allmer, Cristine
    Larson, Melissa C.
    Dueck, Amylou
    Yost, Kathleen
    Warsame, Rahma
    Thanarajasingam, Gita
    Cerhan, James R.
    Paludo, Jonas
    Rajkumar, S. Vincent
    Habermann, Thomas M.
    Nowakowski, Grzegorz S.
    Lin, Yi
    Gertz, Morie A.
    Witzig, Thomas
    Dispenzieri, Angela
    Gonsalves, Wilson, I
    Ansell, Stephen M.
    Thompson, Carrie A.
    Kumar, Shaji K.
    JCO ONCOLOGY PRACTICE, 2022, 18 (08) : 594 - +
  • [42] Novel quality improvement method to reduce cost while improving the quality of patient care: retrospective observational study
    Mate, Kedar S.
    Rakover, Jeffrey
    Cordiner, Kay
    Noble, Amy
    Hassan, Noura
    BMJ QUALITY & SAFETY, 2020, 29 (07) : 586 - 594
  • [43] Top Ten Tips Palliative Care Clinicians Should Know About Designing a Clinical Trial in Palliative Care
    Gurgenci, Taylan
    O'Leary, Cian
    Philip, Jennifer
    Bruera, Eduardo
    Davis, Mellar
    Agar, Meera R.
    Hui, David
    Zimmermann, Camilla
    Yennu, Sriram
    Hardy, Janet
    Mercadante, Sebastiano
    Rosa, William E.
    Good, Phillip
    JOURNAL OF PALLIATIVE MEDICINE, 2024,
  • [44] Risk-Based Quality Management: Who Should Be in the Room and When While Assessing Risks During a Clinical Trial?
    Terry Katz
    Maryrose Petrizzo
    Kamila Novak
    Munish Mehra
    Therapeutic Innovation & Regulatory Science, 2024, 58 : 18 - 20
  • [45] Risk-Based Quality Management: Who Should Be in the Room and When While Assessing Risks During a Clinical Trial?
    Katz, Terry
    Petrizzo, Maryrose
    Novak, Kamila
    Mehra, Munish
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (01) : 18 - 20
  • [46] THE PATIENT IS ENROLLED, BUT WHAT ABOUT THE NURSES? INPATIENT NURSING MANAGEMENT OF TUMOR INFILTRATING LYMPHOCYTE (TIL) CLINICAL TRIAL PATIENTS
    Baird, Emily
    Hess, Valerie
    Kennell, Jamilyn
    Hanchett, Sharon
    Layton, Ashley
    Eaton, Krystle
    ONCOLOGY NURSING FORUM, 2018, 45 (02)
  • [47] IMPROVING PATIENT CARE WHILE CONSIDERING COST EFFECTIVENESS OF NEW ACTIVE PROPHYLAXIS FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV): RESULTS OF A PROSPECTIVE PHASE II TRIAL
    Bernardo, G.
    Palumbo, R.
    Frascaroli, M.
    Bernardo, A.
    Losurdo, A.
    Poggi, G.
    Teragni, C.
    Albanese, D.
    Amatu, A.
    Strada, M. R.
    ANNALS OF ONCOLOGY, 2008, 19 : 275 - 275
  • [48] At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials
    Borno, Hala T.
    Zhang, Li
    Siegel, Adam
    Chang, Emily
    Ryan, Charles J.
    ONCOLOGIST, 2018, 23 (10): : 1242 - 1249
  • [49] A COMPUTERIZED RESPIRATORY CARE ALGORITHM TO STANDARDIZE PATIENT-CARE IN A CONTROLLED CLINICAL-TRIAL
    SITTIG, DF
    MORRIS, AH
    BECK, E
    PACE, NL
    WALLACE, CJ
    GARDNER, RM
    MEDICAL DECISION MAKING, 1987, 7 (04) : 285 - 285
  • [50] An evaluation of the clinical and cost-effectiveness of pulmonary artery catheters in patient management in intensive care: a systematic review and a randomised controlled trial
    Harvey, S.
    Stevens, K.
    Harrison, D.
    Young, D.
    Brampton, W.
    McCabe, C.
    Singer, M.
    Rowan, K.
    HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (29) : 1 - +